Apontis Pharma AG (FRA:APPH)
Germany flag Germany · Delayed Price · Currency is EUR
10.55
0.00 (0.00%)
At close: Sep 9, 2025

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 NaN - NaN
Single Pills
34.42M
Log In
Log In
Log In
Log In
Upgrade
Single Pills Growth
34.26%
Log In
Log In
Log In
Log In
Upgrade
Asthma
9.04M
Log In
Log In
Log In
Log In
Upgrade
COPD (Respiratory Diseases)
3.17M
Log In
Log In
Log In
Log In
Upgrade
COPD (Respiratory Diseases) Growth
-60.23%
Log In
Log In
Log In
Log In
Upgrade
Own Brands (Excluding Single Pills)
1.47M
Log In
Log In
Log In
Log In
Upgrade
Own Brands (Excluding Single Pills) Growth
-28.63%
Log In
Log In
Log In
Log In
Upgrade
Cardiovascular
395.00K
Log In
Log In
Log In
Log In
Upgrade
Cardiovascular Growth
-65.17%
Log In
Log In
Log In
Log In
Upgrade
Co-Marketing - Diabetes
-
Log In
Log In
Log In
Log In
Upgrade
Co-Marketing - Diabetes Growth
-
Log In
Log In
Log In
Log In
Upgrade
Corporate Brands (without Single Pills) - Gynecology
-
Log In
Log In
Log In
Log In
Upgrade
Corporate Brands (without Single Pills) - Gynecology Growth
-
Log In
Log In
Log In
Log In
Upgrade
Corporate Brands (without Single Pills) - Vascular
-
Log In
Log In
Log In
Log In
Upgrade
Corporate Brands (without Single Pills) - Vascular Growth
-
Log In
Log In
Log In
Log In
Upgrade
Dafiro
-
Log In
Log In
Log In
Log In
Upgrade
Dafiro Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 NaN - NaN
Germany
48.47M
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
31.12%
Log In
Log In
Log In
Log In
Upgrade